Sexual dimorphisms in the immune system of catechol-O-methyltransferase knockout mice

Immunobiology

Volumn 217, Issue 8, 2012, Pages 751-760

  Stubelius, Alexandra ^a   Wilhelmson, Anna S ^b   Gogos, Joseph A ^c   Tivesten, Åsa ^b   Islander, Ulrika ^a   Carlsten, Hans ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b UNIVERSITY OF GOTHENBURG   (Sweden)

^c NONE   (United States)

Author keywords

2 Methoxyestradiol; Catechol O methyltransferase; Estradiol metabolism; Immune system; Sex differences

Indexed keywords

CATECHOL METHYLTRANSFERASE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; B LYMPHOCYTE; CELL COUNT; CELL PROLIFERATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOTOXICITY; ENZYME ACTIVITY; ENZYME METABOLISM; FEMALE; IMMUNE SYSTEM; IMMUNOPHENOTYPING; KNOCKOUT MOUSE; LYMPHOCYTE PROLIFERATION; MALE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN PURIFICATION; SEX DIFFERENCE; T LYMPHOCYTE;

ANIMALS; B-LYMPHOCYTES; CATECHOL O-METHYLTRANSFERASE; CELL PROLIFERATION; ENZYME-LINKED IMMUNOSORBENT ASSAY; ESTRADIOL; FEMALE; IMMUNE SYSTEM; IMMUNOGLOBULINS; MALE; MICE; MICE, 129 STRAIN; MICE, INBRED C57BL; MICE, KNOCKOUT; MOLECULAR STRUCTURE; NEUTROPHILS; ORGAN SIZE; SEX FACTORS; SINGLE-CELL ANALYSIS; SPLEEN; T-LYMPHOCYTES; UTERUS;

EID: 84862506292     PISSN: 01712985     EISSN: 18783279     Source Type: Journal    
DOI: 10.1016/j.imbio.2012.04.010     Document Type: Article

References (51)

1. Adrie C., Azoulay E., Francais A., Clec'h C., Darques L., Schwebel C., Nakache D., Jamali S., Goldgran-toledano D., Garrouste-orgeas M., Timsit J.F. Influence of gender on the outcome of severe sepsis: a reappraisal. Chest 2007, 132:1786-1793.
2. Andrews D.M., Smyth M.J. A potential role for RAG-1 in NK cell development revealed by analysis of NK cells during ontogeny. Immunol. Cell Biol. 2010, 88(2):107-116.
3. Ballantyne A.J., Rogers W.A. Sex bias in studies selected for clinical guidelines. J. Womens Health (Larchmt) 2011, 20:1297-1306.
4. Bonifacio M.J., Palma P.N., Almeida L., Soares-DA-Silva P. Catechol-O-methyltransferase and its inhibitors in Parkinson's disease. CNS Drug Rev. 2007, 13:352-379.
5. Brahn E., Banquerigo M.L., Lee J.K., Park E.J., Fogler W.E., Plum S.M. An angiogenesis inhibitor, 2-methoxyestradiol, involutes rat collagen-induced arthritis and suppresses gene expression of synovial vascular endothelial growth factor and basic fibroblast growth factor. J. Rheumatol. 2008, 35:2119-2128.
6. Calati R., Porcelli S., Giegling I., Hartmann A.M., Moller H.J., De Ronchi D., Serretti A., Rujescu D. Catechol-o-methyltransferase gene modulation on suicidal behavior and personality traits: review, meta-analysis and association study. J. Psychiatr. Res. 2011, 45:309-321.
7. Carlsten H., Holmdahl R., Tarkowski A., Nilsson L.A. Oestradiol suppression of delayed-type hypersensitivity in autoimmune (NZB/NZW)F1 mice is a trait inherited from the healthy NZW parental strain. Immunology 1989, 67:205-209.
8. Check Hayden E. Sex bias blights drug studies. Nature 2010, 464:332-333.
9. Chiossone L., Chaix J., Fuseri N., Roth C., Vivier E., Walzer T. Maturation of mouse NK cells is a four-stage developmental program. Blood 2009, 113(22):5488-5496.
10. Crooke P.S., Ritchie M.D., Hachey D.L., Dawling S., Roodi N., Parl F.F. Estrogens, enzyme variants, and breast cancer: a risk model. Cancer Epidemiol. Biomarkers Prev. 2006, 15:1620-1629.
11. Czerkinsky C.C., Nilsson L.A., Nygren H., Ouchterlony O., Tarkowski A. A solid-phase enzyme-linked immunospot (ELISPOT) assay for enumeration of specific antibody-secreting cells. J. Immunol. Methods 1983, 65:109-121.
12. Dawling S., Roodi N., Mernaugh R.L., Wang X., Parl F.F. Catechol-O-methyltransferase (COMT)-mediated metabolism of catechol estrogens: comparison of wild-type and variant COMT isoforms. Cancer Res. 2001, 61:6716-6722.
13. Dawling S., Roodi N., Parl F.F. Methoxyestrogens exert feedback inhibition on cytochrome P450 1A1 and 1B1. Cancer Res. 2003, 63:3127-3132.
14. Doran M.F., Pond G.R., Crowson C.S., O'fallon W.M., Gabriel S.E. Trends in incidence and mortality in rheumatoid arthritis in Rochester, Minnesota, over a forty-year period. Arthritis Rheum. 2002, 46:625-631.
15. Dubey R.K., Gillespie D.G., Zacharia L.C., Barchiesi F., Imthurn B., Jackson E.K. CYP450- and COMT-derived estradiol metabolites inhibit activity of human coronary artery SMCs. Hypertension 2003, 41:807-813.
16. Eriksson A.L., Lorentzon M., Vandenput L., Labrie F., Lindersson M., Syvanen A.C., Orwoll E.S., Cummings S.R., Zmuda J.M., Ljunggren O., Karlsson M.K., Mellstrom D., Ohlsson C. Genetic variations in sex steroid-related genes as predictors of serum estrogen levels in men. J. Clin. Endocrinol. Metab. 2009, 94:1033-1041.
17. Erlandsson M.C., Jonsson C.A., Islander U., Ohlsson C., Carlsten H. Oestrogen receptor specificity in oestradiol-mediated effects on B lymphopoiesis and immunoglobulin production in male mice. Immunology 2003, 108:346-351.
18. Erlandsson M.C., Jonsson C.A., Lindberg M.K., Ohlsson C., Carlsten H. Raloxifene- and estradiol-mediated effects on uterus, bone and B lymphocytes in mice. J. Endocrinol. 2002, 175:319-327.
19. Gogos J.A., Morgan M., Luine V., Santha M., Ogawa S., Pfaff D., Karayiorgou M. Catechol-O-methyltransferase-deficient mice exhibit sexually dimorphic changes in catecholamine levels and behavior. Proc. Natl. Acad. Sci. U. S. A. 1998, 95:9991-9996.
20. Hanna N., Schneider M. Enhancement of tumor metastasis and suppression of natural killer cell activity by beta-estradiol treatment. J. Immunol. 1983, 130:974-980.
21. Harrison P.J., Tunbridge E.M. Catechol-O-methyltransferase (COMT): a gene contributing to sex differences in brain function, and to sexual dimorphism in the predisposition to psychiatric disorders. Neuropsychopharmacology 2008, 33:3037-3045.
22. Islander U., Jochems C., Lagerquist M.K., Forsblad-D'elia H., Carlsten H. Estrogens in rheumatoid arthritis; the immune system and bone. Mol. Cell. Endocrinol. 2011, 335:14-29.
23. Issekutz A.C., Sapru K. Modulation of adjuvant arthritis in the rat by 2-methoxyestradiol: an effect independent of an anti-angiogenic action. Int. Immunopharmacol. 2008, 8:708-716.
24. Jiang H., Xie T., Ramsden D.B., Ho S.L. Human catechol-O-methyltransferase down-regulation by estradiol. Neuropharmacology 2003, 45:1011-1018.
25. Josefsson E., Tarkowski A. Suppression of type II collagen-induced arthritis by the endogenous estrogen metabolite 2-methoxyestradiol. Arthritis Rheum. 1997, 40:154-163.
26. Kanasaki K., Palmsten K., Sugimoto H., Ahmad S., Hamano Y., Xie L., Parry S., Augustin H.G., Gattone V.H., Folkman J., Strauss J.F., Kalluri R. Deficiency in catechol-O-methyltransferase and 2-methoxyoestradiol is associated with pre-eclampsia. Nature 2008, 453:1117-1121.
27. Kavelaars A., Cobelens P.M., Teunis M.A., Heijnen C.J. Changes in innate and acquired immune responses in mice with targeted deletion of the dopamine transporter gene. J. Neuroimmunol. 2005, 161:162-168.
28. Kim A.M., Tingen C.M., Woodruff T.K. Sex bias in trials and treatment must end. Nature 2010, 465:688-689.
29. Lavallee T.M., Zhan X.H., Herbstritt C.J., Kough E.C., Green S.J., Pribluda V.S. 2-Methoxyestradiol inhibits proliferation and induces apoptosis independently of estrogen receptors alpha and beta. Cancer Res. 2002, 62:3691-3697.
30. Lindberg M.K., Weihua Z., Andersson N., Moverare S., Gao H., Vidal O., Erlandsson M., Windahl S., Andersson G., Lubahn D.B., Carlsten H., Dahlman-Wright K., Gustafsson J.A., Ohlsson C. Estrogen receptor specificity for the effects of estrogen in ovariectomized mice. J. Endocrinol. 2002, 174:167-178.
31. Lundqvist H., Dahlgren C. Isoluminol-enhanced chemiluminescence: a sensitive method to study the release of superoxide anion from human neutrophils. Free Radic. Biol. Med. 1996, 20:785-792.
32. Mannisto P.T., Kaakkola S. Catechol-O-methyltransferase (COMT): biochemistry, molecular biology, pharmacology, and clinical efficacy of the new selective COMT inhibitors. Pharmacol. Rev. 1999, 51:593-628.
33. Marotti T., Sirotkovic M., Pavelic J., Gabrilovac J., Pavelic K. In vivo effect of progesteron and estrogen on thymus mass and T-cell functions in female mice. Horm. Metab. Res. 1984, 16(4):201-203.
34. Martucci C.P., Fishman J. P450 enzymes of estrogen metabolism. Pharmacol. Ther. 1993, 57:237-257.
35. Nilsson N., Carlsten H. Estrogen induces suppression of natural killer cell cytotoxicity and augmentation of polyclonal B cell activation. Cell. Immunol. 1994, 158:131-139.
36. Palacios R. Concanavalin A triggers T lymphocytes by directly interacting with their receptors for activation. J. Immunol. 1982, 128:337-342.
37. Parl F.F., Dawling S., Roodi N., Crooke P.S. Estrogen metabolism and breast cancer: a risk model. Ann. N. Y. Acad. Sci. 2009, 1155:68-75.
38. Sanders V.M., Straub R.H. Norepinephrine, the beta-adrenergic receptor, and immunity. Brain Behav. Immun. 2002, 16:290-332.
39. Schmidt M., Hartung R., Capellino S., Cutolo M., Pfeifer-Leeg A., Straub R.H. Estrone/17beta-estradiol conversion to, and tumor necrosis factor inhibition by estrogen metabolites in synovial cells of patients with rheumatoid arthritis and patients with osteoarthritis. Arthritis Rheum. 2009, 60:2913-2922.
40. Straub R.H. The complex role of estrogens in inflammation. Endocr. Rev. 2007, 28:521-574.
41. Stubelius A., Andreasson E., Karlsson A., Ohlsson C., Tivesten A., Islander U., Carlsten H. Role of 2-methoxyestradiol as inhibitor of arthritis and osteoporosis in a model of postmenopausal rheumatoid arthritis. Clin. Immunol. 2011, 140:37-46.
42. Tenorio-Laranga J., Mannisto P.T., Karayiorgou M., Gogos J.A., Garcia-Horsman J.A. Sex-dependent compensated oxidative stress in the mouse liver upon deletion of catechol O-methyltransferase. Biochem. Pharmacol. 2009, 77:1541-1552.
43. Teunis M.A., Heijnen C.J., Cools A.R., Kavelaars A. Reduced splenic natural killer cell activity in rats with a hyperreactive dopaminergic system. Psychoneuroendocrinology 2004, 29:1058-1064.
44. Truett G.E., Heeger P., Mynatt R.L., Truett A.A., Walker J.A., Warman M.L. Preparation of PCR-quality mouse genomic DNA with hot sodium hydroxide and tris (HotSHOT). Biotechniques 2000, 29(52):54.
45. Tunbridge E.M., Harrison P.J. Importance of the COMT gene for sex differences in brain function and predisposition to psychiatric disorders. Curr. Top. Behav. Neurosci. 2011, 8:119-140.
46. Vivier E., Tomasello E., Baratin M., Walzer T., Ugolini S. Functions of natural killer cells. Nat. Immunol. 2008, 9:503-510.
47. Whitacre C.C. Sex differences in autoimmune disease. Nat. Immunol. 2001, 2:777-780.
48. Wilhelmson A.S., Bourghardt-Fagman J., Gogos J.A., Fogelstrand P., Tivesten A. Catechol-O-methyltransferase is dispensable for vascular protection by estradiol in mouse models of atherosclerosis and neointima formation. Endocrinology 2011, 152(12):4683-4690.
49. Zacharia L.C., Gogos J.A., Karayiorgou M., Jackson E.K., Gillespie D.G., Barchiesi F., Dubey R.K. Methoxyestradiols mediate the antimitogenic effects of 17beta-estradiol: direct evidence from catechol-O-methyltransferase-knockout mice. Circulation 2003, 108:2974-2978.
50. Zhu B.T., Conney A.H. Functional role of estrogen metabolism in target cells: review and perspectives. Carcinogenesis 1998, 19:1-27.
51. Zhu B.T., Evaristus E.N., Antoniak S.K., Sarabia S.F., Ricci M.J., Liehr J.G. Metabolic deglucuronidation and demethylation of estrogen conjugates as a source of parent estrogens and catecholestrogen metabolites in Syrian hamster kidney, a target organ of estrogen-induced tumorigenesis. Toxicol. Appl. Pharmacol. 1996, 136:186-193.